SUZHOU, China, Dec. 18, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN027, an independently developed innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback